Site Search
Search Results
House Passes Legislation That Won’t Improve Health Outcomes
CHARLESTON, W. VA . – Today, the West Virginia House passed House Bill 4753, which was supposed to ensure biomarker testing, a game changer in the fight against cancer and an essential step in accessing precision medicine treatments, is covered by more insurance ... Network (ACS CAN) in West Virginia: "The American Cancer Society Cancer Action Network (ACS CAN) urges the Senate to amend House Bill 4753, the biomarker testing legislation, to allow West Virginians to get the testing they need and not fall farther behind other states. West Virginia ...
Ensuring Access to Quality Care
... comprehensive health insurance including Medicaid and will support efforts to curb the availability of inadequate health plans. • Access to Biomarker Testing: ACS CAN will advocate for improved coverage of comprehensive biomarker testing, including extending the coverage requirement to state-regulated private plans. Biomarker testing is an important step to ...
Lawmakers Take Critical Step to Revolutionize Cancer Treatment in North Carolina
... in efforts to reduce the cancer burden by introducing House Bill 567 . If passed, the legislation would allow more North Carolinians to access biomarker testing, which has become an increasingly important part of cancer care. Patients who are diagnosed with certain types of cancer can receive biomarker testing to help providers determine the most effective form of treatment. It can save patients from starting treatments that may not end ...
Lawmakers Take Critical Step to Revolutionize Cancer Treatment in Georgia, State’s Second Leading Cause of Death
ATLANTA, GA – January 31, 2023 – Today, Rep. Sharon Cooper filed a bill (HB85) that will allow more Georgians to receive biomarker testing – a routine step in accessing personalized medicine treatments that has become an increasingly important part of cancer care in recent ... significant impact in improving survivorship and quality of life. Progress in the fight against cancer has been in part due to advances in biomarker testing which allows physicians to match patients with the most effective treatment for their specific cancer. Unfortunately, too many ...
‘Game-Changing’ Bill Becomes Law in Iowa, Opening the Door to Precision Medicine for More Patients
DES MOINES, Iowa – Iowa Governor Kim Reynolds signed a bill today, expanding access to biomarker testing to more patients statewide. The American Cancer Society Cancer Action Network (ACS CAN) and its team of volunteers, including cancer ... opens new opportunities for Iowans to receive the best care they can to win the battle against cancer. I’ve seen firsthand what a difference biomarker testing can make. These necessary advancements will be available to patients across Iowa,” said Governor Kim Reynolds. In 2024, ...
ACCESS TO CARE
... 138% of the federal poverty level access to comprehensive, affordable health insurance coverage. Learn more about our Medicaid Expansion work Biomarker Testing ACS CAN will advocate for improved coverage of comprehensive biomarker testing. Progress in improving cancer outcomes increasingly involves the use of precision medicine, which uses information about a ...
Legislation Introduced to Revolutionize Cancer Treatment in Maine
... and sent for reference to the Health Coverage, Insurance and Financial Services Committee. This bill will allow more Mainers to receive biomarker testing – a routine step in accessing personalized medicine treatments that has become an increasingly important part of cancer care in recent ... its significant impact in improving survivorship and quality of life. Progress in the fight against cancer has been in part due to advances in biomarker testing which allows physicians to match patients with the most effective treatment for their specific cancer. Unfortunately, private ...
Oregonians Deserve Access to the Best Tools in Treating Serious Disease
SALEM, Oregon –– Improved coverage of comprehensive biomarker testing is crucial for Oregonians to have the best chance of treating and defeating cancer and other diseases. The American Cancer Society Cancer ... for many patients. Legislation is needed to ensure more Oregonians, regardless of income, geography, race, ethnicity, or age, can access biomarker testing. Similar legislation has passed in 24 states including California, Texas, Georgia, Arizona and Mississippi. The following ...
2024 North Carolina Policy Forum
Join us for an important conversation on The Future of Cancer Care: Biomarker Testing. Progress in improving cancer outcomes increasingly involves the use of precision medicine, which uses information about a person's own genes or proteins to better diagnose and treat diseases like cancer. Biomarker testing is an important step to accessing precision medicine which includes targeted therapies that can lead to improved survivorship and ...
Cancer Advocates to Convene on Beacon Hill to Urge Lawmakers to Reduce Health Disparities
... Advocates will ask lawmakers to support legislation (House Bill 1227/Senate Bill 809) that would ensure insurance coverage of comprehensive biomarker testing , which uses information about a person’s own genes or proteins to prevent, diagnose or treat diseases like cancer. Unfortunately, not all communities are benefiting from the latest advancements in biomarker testing and precision medicine due to financial barriers. Improving coverage for biomarker testing across insurance types will help ...
Type
- Action (8) Apply Action filter
- Basic page (58) Apply Basic page filter
- Event (6) Apply Event filter
- Landing Page (1) Apply Landing Page filter
- Press Release (223) Apply Press Release filter
- Resource (16) Apply Resource filter
- State Priority (37) Apply State Priority filter
- Update (10) Apply Update filter
- Webform (3) Apply Webform filter
Priority Issue
State
- New York (36) Apply New York filter
- Ohio (18) Apply Ohio filter
- Pennsylvania (17) Apply Pennsylvania filter
- California (14) Apply California filter
- North Carolina (14) Apply North Carolina filter
- Washington (14) Apply Washington filter
- Hawaii (13) Apply Hawaii filter
- Maine (13) Apply Maine filter
- New Jersey (13) Apply New Jersey filter
- Tennessee (13) Apply Tennessee filter
- Illinois (11) Apply Illinois filter
- Colorado (10) Apply Colorado filter
- Delaware (10) Apply Delaware filter
- Florida (10) Apply Florida filter
- Massachusetts (10) Apply Massachusetts filter
- Connecticut (8) Apply Connecticut filter
- Georgia (8) Apply Georgia filter
- Kentucky (8) Apply Kentucky filter
- National (8) Apply National filter
- Nevada (7) Apply Nevada filter
- Vermont (7) Apply Vermont filter
- Maryland (6) Apply Maryland filter
- Mississippi (6) Apply Mississippi filter
- New Hampshire (6) Apply New Hampshire filter
- Arizona (5) Apply Arizona filter
- Iowa (5) Apply Iowa filter
- Oklahoma (5) Apply Oklahoma filter
- Texas (5) Apply Texas filter
- West Virginia (5) Apply West Virginia filter
- Indiana (4) Apply Indiana filter
- Minnesota (4) Apply Minnesota filter
- New Mexico (4) Apply New Mexico filter
- Oregon (4) Apply Oregon filter
- Nebraska (3) Apply Nebraska filter
- Rhode Island (2) Apply Rhode Island filter
- Alaska (1) Apply Alaska filter
- Louisiana (1) Apply Louisiana filter
- Michigan (1) Apply Michigan filter
- South Dakota (1) Apply South Dakota filter
Policy Issue
- Research, Funding and Drug Development (7) Apply Research, Funding and Drug Development filter
- Access to Health Care (2) Apply Access to Health Care filter
- Eye on Cancer Care (1) Apply Eye on Cancer Care filter
- Health Equity (1) Apply Health Equity filter
- Patient Quality of Life (1) Apply Patient Quality of Life filter